Your browser doesn't support javascript.
loading
MAP4K4 controlled integrin ß1 activation and c-Met endocytosis are associated with invasive behavior of medulloblastoma cells.
Tripolitsioti, Dimitra; Kumar, Karthiga Santhana; Neve, Anuja; Migliavacca, Jessica; Capdeville, Charles; Rushing, Elisabeth J; Ma, Min; Kijima, Noriyuki; Sharma, Ashish; Pruschy, Martin; McComb, Scott; Taylor, Michael D; Grotzer, Michael A; Baumgartner, Martin.
Afiliação
  • Tripolitsioti D; University Children's Hospital Zürich, Department of Oncology, Children's Research Center, Zürich, Switzerland.
  • Kumar KS; University Children's Hospital Zürich, Department of Oncology, Children's Research Center, Zürich, Switzerland.
  • Neve A; University Children's Hospital Zürich, Department of Oncology, Children's Research Center, Zürich, Switzerland.
  • Migliavacca J; University Children's Hospital Zürich, Department of Oncology, Children's Research Center, Zürich, Switzerland.
  • Capdeville C; University Children's Hospital Zürich, Department of Oncology, Children's Research Center, Zürich, Switzerland.
  • Rushing EJ; Institute of Neuropathology, University Hospital Zürich, Zürich, Switzerland.
  • Ma M; University Children's Hospital Zürich, Department of Oncology, Children's Research Center, Zürich, Switzerland.
  • Kijima N; Division of Neurosurgery, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
  • Sharma A; Department of Radiation Oncology, University Hospital Zürich, Zürich, Switzerland.
  • Pruschy M; Department of Radiation Oncology, University Hospital Zürich, Zürich, Switzerland.
  • McComb S; University Children's Hospital Zürich, Department of Oncology, Children's Research Center, Zürich, Switzerland.
  • Taylor MD; Division of Neurosurgery, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
  • Grotzer MA; University Children's Hospital Zürich, Department of Oncology, Children's Research Center, Zürich, Switzerland.
  • Baumgartner M; University Children's Hospital Zürich, Department of Oncology, Zürich, Switzerland.
Oncotarget ; 9(33): 23220-23236, 2018 May 01.
Article em En | MEDLINE | ID: mdl-29796184
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Oncotarget Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Oncotarget Ano de publicação: 2018 Tipo de documento: Article